Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker in COVID-19 patients: a systematic review.

Saved in:
Bibliographic Details
Title: Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker in COVID-19 patients: a systematic review.
Authors: Lobato-Martínez E; Internal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. ester.lobatom@gmail.com., Sanchez-Martinez R, de-Miguel Balsa E, Ramos-Rincon JM
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2024 Jan; Vol. 28 (2), pp. 852-860.
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729
DOI:10.26355/eurrev_202401_35086